Literature DB >> 16861732

Ex vivo reversal of in vivo transdifferentiation in mesothelial cells grown from peritoneal dialysate effluents.

Regina Vargha1, Michaela Endemann, Klaus Kratochwill, Andrea Riesenhuber, Nikolaus Wick, Anne-Marie Krachler, Laura Malaga-Dieguez, Christoph Aufricht.   

Abstract

BACKGROUND: During peritoneal dialysis (PD), epithelial-mesenchymal transition (EMT) is likely involved in aberrant healing and progressive peritoneal fibrosis. Recently, EMT of the kidney was actively reversed into the opposite direction, into mesenchymal-epithelial transition (MET), by treatment with bone morphogenic protein-7 (BMP-7). In this study, the potential for ex vivo interconversion of in vivo transdifferentiation processes was investigated in mesothelial cells.
METHODS: In vivo EMT was assessed in mesothelial cell cultures randomly grown from peritoneal effluents of seven patients on chronic PD. Then, ex vivo treatment with modulating factors was performed by incubating cobblestone-like cell cultures with transforming growth factor (TGF- beta1) and fibroblast-like cultures with BMP-7. Effects were assessed by morphological characterization, western analysis and reverse transcription-polymerase chain reaction of marker proteins ezrin and alpha-smooth muscle actin (alpha-SMA).
RESULTS: PD caused progressive in vivo EMT with loss of the epithelial phenotype in the majority of mesothelial cell cultures over a 12-month period. EMT was reproducible by ex vivo treatment of cultured cells with TGF-beta1, converting the epithelial to the fibroblast-like phenotype. Ex vivo treatment with BMP-7 reversed in vivo and ex vivo EMT. During rhBMP-7 incubation the fibroblast-like growth pattern reversed into a more epithelial morphology, the expression of ezrin increased and alpha-SMA decreased.
CONCLUSION: Our study shows that modulating factors of transdifferentiation, such as BMP-7, may be attractive tools in the balance between normal healing and aberrant profibrotic processes in mesothelial cells during peritoneal dialysis. Peritoneal-effluent-derived mesothelial cells are not mere biomarkers for in vivo EMT in the peritoneal cavity, but also represent an assay to test ex vivo interventions to reverse the profibrotic phenotype.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16861732     DOI: 10.1093/ndt/gfl355

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  23 in total

Review 1.  Encapsulating peritoneal sclerosis: the state of affairs.

Authors:  Mario R Korte; Denise E Sampimon; Michiel G H Betjes; Raymond T Krediet
Journal:  Nat Rev Nephrol       Date:  2011-08-02       Impact factor: 28.314

Review 2.  Studies of bone morphogenetic protein-based surgical repair.

Authors:  Kevin W-H Lo; Bret D Ulery; Keshia M Ashe; Cato T Laurencin
Journal:  Adv Drug Deliv Rev       Date:  2012-04-02       Impact factor: 15.470

3.  Quercetin protects human mesothelial cells against exposure to peritoneal dialysis fluid.

Authors:  Andrea Riesenhuber; David C Kasper; Regina Vargha; Michaela Endemann; Christoph Aufricht
Journal:  Pediatr Nephrol       Date:  2007-04-25       Impact factor: 3.714

4.  Epithelial-to-mesenchymal transition of peritoneal mesothelial cells is regulated by an ERK/NF-kappaB/Snail1 pathway.

Authors:  Raffaele Strippoli; Ignacio Benedicto; Maria Luisa Pérez Lozano; Ana Cerezo; Manuel López-Cabrera; Miguel A del Pozo
Journal:  Dis Model Mech       Date:  2008-10-28       Impact factor: 5.758

5.  Gremlin promotes peritoneal membrane injury in an experimental mouse model and is associated with increased solute transport in peritoneal dialysis patients.

Authors:  Imad Siddique; Simon P Curran; Ayesha Ghayur; Limin Liu; Wei Shi; Catherine M Hoff; Azim S Gangji; K Scott Brimble; Peter J Margetts
Journal:  Am J Pathol       Date:  2014-09-03       Impact factor: 4.307

6.  HGF and BMP-7 ameliorate high glucose-induced epithelial-to-mesenchymal transition of peritoneal mesothelium.

Authors:  Min-A Yu; Kyung-Sook Shin; Jung Hye Kim; Yong-Il Kim; Soon Sup Chung; Sun-Hee Park; Yong-Lim Kim; Duk-Hee Kang
Journal:  J Am Soc Nephrol       Date:  2009-02-04       Impact factor: 10.121

7.  Inhibition of transforming growth factor-activated kinase 1 (TAK1) blocks and reverses epithelial to mesenchymal transition of mesothelial cells.

Authors:  Raffaele Strippoli; Ignacio Benedicto; Maria Luisa Perez Lozano; Teijo Pellinen; Pilar Sandoval; Manuel Lopez-Cabrera; Miguel Angel del Pozo
Journal:  PLoS One       Date:  2012-02-27       Impact factor: 3.240

8.  Dynamic actin remodeling during epithelial-mesenchymal transition depends on increased moesin expression.

Authors:  Jennifer Haynes; Jyoti Srivastava; Nikki Madson; Torsten Wittmann; Diane L Barber
Journal:  Mol Biol Cell       Date:  2011-10-26       Impact factor: 4.138

9.  miRNA589 regulates epithelial-mesenchymal transition in human peritoneal mesothelial cells.

Authors:  Ke Zhang; Hao Zhang; Xun Zhou; Wen-bin Tang; Li Xiao; Ying-hong Liu; Hong Liu; You-ming Peng; Lin Sun; Fu-you Liu
Journal:  J Biomed Biotechnol       Date:  2012-10-03

Review 10.  Mechanisms of epithelial-mesenchymal transition of peritoneal mesothelial cells during peritoneal dialysis.

Authors:  Hi Bahl Lee; Hunjoo Ha
Journal:  J Korean Med Sci       Date:  2007-12       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.